CompareMarketResearchRequest a sample
Home / Healthcare / Point-of-Care Respiratory Diagnostic Panels

Healthcare · Market report

Point-of-Care Respiratory Diagnostic Panels Market Size, Share and Forecast 2026-2036

The global point-of-care respiratory diagnostic panels market is worth USD 2.2 bn in 2026 and is forecast to reach USD 4.2 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Molecular multiplex panels is the largest by test type segment.

USD 2.2 bnMarket size 2026
USD 4.2 bnForecast 2036
6.5%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global point-of-care respiratory diagnostic panels market is worth USD 2.2 bn in 2026 and is forecast to reach USD 4.2 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Molecular multiplex panels is the largest by test type segment.

ScopeRapid multiplex respiratory tests run at or near the patient, detecting influenza, COVID-19, RSV and other pathogens in a single sample, using molecular and antigen platforms in clinics, hospitals and pharmacies.
IndustryHealthcare
Value 2025USD 2.1 bn
Value 2026USD 2.2 bn
Value 2036USD 4.2 bn
CAGR 2026-20366.5%
Volume 2026111 million tests
Volume 2036198 million tests
Average price 2026USD 20.1 per test
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Point-of-Care Respiratory Diagnostic Panels market size and forecast, 2026-2036

Exhibit 1The global point-of-care respiratory diagnostic panels market is forecast to grow from USD 2.2 bn in 2026 to USD 4.2 bn by 2036, a rise of 88%Global market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 6.5%
Point-of-Care Respiratory Diagnostic Panels market value, 2025 to 2036Market value by year. 2025: USD 2.1 bn; 2026: USD 2.2 bn; 2027: USD 2.4 bn; 2028: USD 2.5 bn; 2029: USD 2.7 bn; 2030: USD 2.9 bn; 2031: USD 3.0 bn; 2032: USD 3.2 bn; 2033: USD 3.5 bn; 2034: USD 3.7 bn; 2035: USD 3.9 bn; 2036: USD 4.2 bn. Compound annual growth rate 2026 to 2036: 6.5%.20252.2 bn20263.0 bn20314.2 bn20366.5% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 2.2 bn
2027USD 2.4 bn
2028USD 2.5 bn
2029USD 2.7 bn
2030USD 2.9 bn
2031USD 3.0 bn
2032USD 3.2 bn
2033USD 3.5 bn
2034USD 3.7 bn
2035USD 3.9 bn
2036USD 4.2 bn

Point-of-Care Respiratory Diagnostic Panels market segmentation

By test type

Exhibit 2Molecular multiplex panels is the largest segment by test type, with 36.0% of 2026 revenueEstimated share of 2026 global revenue, by test type
Point-of-Care Respiratory Diagnostic Panels market share by test type, 2026Share of 2026 revenue by test type. Molecular multiplex panels: 36.0%; Molecular single and dual target: 30.0%; Rapid antigen multiplex: 24.0%; Other: 10.0%.Molecular multiplex panels36.0%Molecular single and dual target30.0%Rapid antigen multiplex24.0%Other10.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Molecular multiplex panels36.0%49.3%USD 801 mn9.9%
Molecular single and dual target30.0%22.3%USD 668 mn3.4%
Rapid antigen multiplex24.0%20.6%USD 534 mn4.9%
Other10.0%7.8%USD 223 mn3.9%

By setting

Exhibit 3Physician offices and urgent care adds the most revenue by setting, growing from USD 668 mn in 2026 to USD 1.3 bn by 2036Estimated revenue in USD by setting, 2026 and 2036 forecast
Point-of-Care Respiratory Diagnostic Panels market by setting, 2026 and 2036Revenue by setting in 2026 and 2036. Hospitals and emergency departments: USD 846 mn in 2026, USD 1.5 bn in 2036, change +72%; Physician offices and urgent care: USD 668 mn in 2026, USD 1.3 bn in 2036, change +98%; Retail pharmacies and clinics: USD 378 mn in 2026, USD 714 mn in 2036, change +89%; Home and other: USD 334 mn in 2026, USD 691 mn in 2036, change +107%.20262036 forecastChangeHospitals and emergency departments+72%846 mn1.5 bnPhysician offices and urgent care+98%668 mn1.3 bnRetail pharmacies and clinics+89%378 mn714 mnHome and other+107%334 mn691 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals and emergency departments38.0%34.8%USD 846 mn5.6%
Physician offices and urgent care30.0%31.6%USD 668 mn7.0%
Retail pharmacies and clinics17.0%17.1%USD 378 mn6.5%
Home and other15.0%16.5%USD 334 mn7.5%

By pathogen

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Influenza A and B30.0%26.0%USD 668 mn5.0%
SARS-CoV-226.0%24.0%USD 579 mn5.7%
RSV14.0%18.0%USD 312 mn9.2%
Strep and bacterial16.0%16.0%USD 356 mn6.5%
Multi-pathogen syndromic14.0%16.0%USD 312 mn7.9%

By format

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Cartridge-based44.0%46.0%USD 979 mn7.0%
Lateral flow readers30.0%26.0%USD 668 mn5.0%
Benchtop sample-to-answer26.0%28.0%USD 579 mn7.3%

By sales

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Instrument and reader placement26.0%24.0%USD 579 mn5.7%
Test cassettes and panels66.0%68.0%USD 1.5 bn6.8%
Software and service8.0%8.0%USD 178 mn6.5%

Top 25 countries for point-of-care respiratory diagnostic panels by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 88.0% of 2026 revenue and the 25 countries below together hold 96.4%.

Exhibit 4United States is the largest country market at USD 1.1 bn in 2026, and the three largest countries hold 65.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Point-of-Care Respiratory Diagnostic Panels market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 1.1 bn, 50.0%; China: USD 223 mn, 10.0%; Germany: USD 111 mn, 5.0%; Japan: USD 111 mn, 5.0%; United Kingdom: USD 89 mn, 4.0%; France: USD 89 mn, 4.0%; Italy: USD 67 mn, 3.0%; Spain: USD 56 mn, 2.5%; Canada: USD 56 mn, 2.5%; Australia: USD 45 mn, 2.0%.United States1.1 bn 50.0%China223 mn 10.0%Germany111 mn 5.0%Japan111 mn 5.0%United Kingdom89 mn 4.0%France89 mn 4.0%Italy67 mn 3.0%Spain56 mn 2.5%Canada56 mn 2.5%Australia45 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 1.1 bn50.0%USD 2.1 bn6.5%
2ChinaUSD 223 mn10.0%USD 501 mn8.5%
3GermanyUSD 111 mn5.0%USD 188 mn5.4%
4JapanUSD 111 mn5.0%USD 188 mn5.4%
5United KingdomUSD 89 mn4.0%USD 150 mn5.4%
6FranceUSD 89 mn4.0%USD 150 mn5.4%
7ItalyUSD 67 mn3.0%USD 113 mn5.4%
8SpainUSD 56 mn2.5%USD 96 mn5.6%
9CanadaUSD 56 mn2.5%USD 96 mn5.6%
10AustraliaUSD 45 mn2.0%USD 75 mn5.4%
11SwitzerlandUSD 42 mn1.9%USD 75 mn6.0%
12NetherlandsUSD 25 mn1.1%USD 45 mn6.1%
13South KoreaUSD 18 mn0.8%USD 33 mn6.1%
14BelgiumUSD 15 mn0.7%USD 26 mn6.0%
15SwedenUSD 12 mn0.6%USD 23 mn6.1%
16MexicoUSD 11 mn0.5%USD 28 mn9.9%
17PolandUSD 9.6 mn0.4%USD 25 mn9.9%
18IndiaUSD 8.7 mn0.4%USD 23 mn10.0%
19TurkeyUSD 8.0 mn0.4%USD 20 mn9.8%
20AustriaUSD 7.3 mn0.3%USD 13 mn6.2%
21TaiwanUSD 6.9 mn0.3%USD 13 mn6.2%
22BrazilUSD 6.5 mn0.3%USD 17 mn10.0%
23IsraelUSD 6.0 mn0.3%USD 15 mn9.9%
24DenmarkUSD 5.8 mn0.3%USD 10 mn6.1%
25Saudi ArabiaUSD 5.6 mn0.2%USD 14 mn9.5%
Rest of worldUSD 80 mn3.6%USD 155 mn6.8%
Exhibit 5United States and China account for 64% of the USD 2.0 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Point-of-Care Respiratory Diagnostic Panels market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 2.2 bn. United States: +USD 972 mn; China: +USD 279 mn; Germany: +USD 77 mn; Japan: +USD 77 mn; United Kingdom: +USD 61 mn; 20 other countries: +USD 411 mn; Rest of world: +USD 75 mn. Market value 2036: USD 4.2 bn.Market value 20262.2 bnUnited States+972 mnChina+279 mnGermany+77 mnJapan+77 mnUnited Kingdom+61 mn20 other countries+411 mnRest of world+75 mnMarket value 20364.2 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Abbott
  • Roche
  • QuidelOrtho
  • bioMérieux
  • Cepheid
  • Becton Dickinson

Group 2: Regional and specialist players

  • Hologic
  • SD Biosensor
  • OraSure Technologies
  • Qiagen
  • DiaSorin

Group 3: Emerging and niche players

  • Sekisui Diagnostics
  • Coris BioConcept
  • Talis Biomedical

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the point-of-care respiratory diagnostic panels market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.5% is calculated from the resulting values.

The market is divided by test type, by setting, by pathogen, by format, by sales. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the point-of-care respiratory diagnostic panels market?

The global point-of-care respiratory diagnostic panels market is estimated at USD 2.1 bn in 2025 and USD 2.2 bn in 2026.

How fast will the point-of-care respiratory diagnostic panels market grow?

It is forecast to reach USD 4.2 bn by 2036, a compound annual growth rate of 6.5% from 2026, an increase of USD 2.0 bn.

Which country is the largest market for point-of-care respiratory diagnostic panels?

United States is the largest market by revenue at USD 1.1 bn in 2026, 50.0% of the global total. The three largest countries together hold 65.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 8.5% a year from 2026 to 2036.

Which point-of-care respiratory diagnostic panels segment is largest?

In the by test type split, Molecular multiplex panels is the largest segment with 36.0% of 2026 revenue.

Who are the leading point-of-care respiratory diagnostic panels companies?

Global leaders include Abbott, Roche, QuidelOrtho, bioMérieux.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Point of Care Testing Polymerase Chain Reaction →

All Healthcare markets →

Request a sample